全文获取类型
收费全文 | 7974篇 |
免费 | 448篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 119篇 |
妇产科学 | 140篇 |
基础医学 | 822篇 |
口腔科学 | 349篇 |
临床医学 | 431篇 |
内科学 | 2018篇 |
皮肤病学 | 317篇 |
神经病学 | 574篇 |
特种医学 | 352篇 |
外科学 | 1338篇 |
综合类 | 58篇 |
一般理论 | 2篇 |
预防医学 | 198篇 |
眼科学 | 89篇 |
药学 | 590篇 |
中国医学 | 12篇 |
肿瘤学 | 995篇 |
出版年
2023年 | 51篇 |
2022年 | 99篇 |
2021年 | 199篇 |
2020年 | 101篇 |
2019年 | 142篇 |
2018年 | 199篇 |
2017年 | 144篇 |
2016年 | 163篇 |
2015年 | 197篇 |
2014年 | 211篇 |
2013年 | 261篇 |
2012年 | 376篇 |
2011年 | 399篇 |
2010年 | 219篇 |
2009年 | 208篇 |
2008年 | 378篇 |
2007年 | 416篇 |
2006年 | 351篇 |
2005年 | 395篇 |
2004年 | 367篇 |
2003年 | 376篇 |
2002年 | 370篇 |
2001年 | 271篇 |
2000年 | 264篇 |
1999年 | 248篇 |
1998年 | 88篇 |
1997年 | 74篇 |
1996年 | 78篇 |
1995年 | 54篇 |
1994年 | 52篇 |
1993年 | 45篇 |
1992年 | 173篇 |
1991年 | 160篇 |
1990年 | 157篇 |
1989年 | 164篇 |
1988年 | 139篇 |
1987年 | 126篇 |
1986年 | 93篇 |
1985年 | 101篇 |
1984年 | 67篇 |
1983年 | 58篇 |
1982年 | 30篇 |
1981年 | 28篇 |
1979年 | 63篇 |
1978年 | 36篇 |
1977年 | 23篇 |
1975年 | 24篇 |
1974年 | 43篇 |
1968年 | 23篇 |
1967年 | 22篇 |
排序方式: 共有8470条查询结果,搜索用时 15 毫秒
1.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene
下载免费PDF全文
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
2.
Hirotaka Koizuml Mikita Morita Shinya Mikaml Eiichi Shibayama Toshiyuki Uchikoshi 《Pathology international》1998,48(2):93-101
The Trk family of tyrosine protein kinase receptors plays a significant role in the development and maintenance of neural tissues. It has been recently shown that Trk receptors are also expressed by a wide range of normal non-neuronal tissues in humans in a cell type-specific manner. In the present study, the expression patterns of TrkA in 337 non-neuronal invasive carcinomas of 15 different human tissues were investigated immunohistochemically. Overall, 133 (39%), 101 (30%) and 103 (31%) tumors exhibited strong, moderate and no TrkA Immunoreactivity, respectively. Esophageal and thyroid carcinomas expressed high levels of TrkA, whereas the levels in gastric and colon cancers were low. TrkA expression was detected not only in carcinomas originating from TrkA-positive normal counterpart tissues, Including the esophagus, breast, lung and uterus, but also in those from TrkA-negative tissues/cells of the thyroid, liver and ovary. Immunostaining for nerve growth factor-β, the specific ligand for TrkA, in esophageal and breast carcinomas demonstrated its immunoreactivity in stromal fibroblasts and some TrkA-expressing tumor cells. These results suggest that paracrine/autocrine regulation via stromal/tumoral NGF-tumoral TrkA interaction may be involved In the growth of certain non-neuronal carcinomas. 相似文献
3.
We studied two patients with nonfamilial olivopontocerebellar atrophy with skeletal myoclonus. Palatal or skeletal myoclonus is probably not a coincidental finding but another manifestation of the underlying disease. In both cases, the myoclonus was suppressed by administration of trihexyphenidyl, indicating a cholinergic disorder. 相似文献
4.
5.
Pituitary stalk meningioma: case report 总被引:1,自引:0,他引:1
We report a 45-year-old woman with a meningioma which was in contact with only the pituitary stalk on MRI. As the pituitary
stalk has no dura mater, we suggest this tumour may have originated from the arachnoid membrane of the pituitary stalk. Though
some reports have shown that meningiomas can arise from sites lacking a dural component, this is the first report of a meningioma
originating from the pituitary stalk.
Received: 21 December 1995 Accepted: 26 February 1996 相似文献
6.
7.
Plasma immunoreactive human atrial natriuretic peptide (hANP) levels were measured in 9 patients with chronic renal failure treated with maintenance hemodialysis in order to evaluate the effects of fluid removal and osmotic pressure. Under hemodialysis without fluid removal plasma hANP levels remained unchanged, but the levels were significantly decreased during extra-corporeal ultrafiltration (p less than 0.01). The present study provided strong evidence that the fall in plasma hANP levels in hemodialysis patients is mainly due to the reduction in circulating plasma volume. 相似文献
8.
M. Ohshima A. Yokoyama H. Ohnishi H. Hamada N. Kohno J. Higaki T. Naka 《Clinical and experimental allergy》2007,37(5):735-742
BACKGROUND: Enhanced expression of the suppressor of cytokine signalling (SOCS)-5 might be of therapeutic benefit for T-helper type 2 (Th2) dominant diseases, as its expression is reported to result in a reduction of Th2 differentiation in vitro due to the inhibition of IL-4 signalling. OBJECTIVE: To investigate the regulatory role of SOCS-5 in vivo, we explored the phenotype of an experimental asthma model developed in SOCS-5 transgenic (Tg) mice. METHODS: The SOCS-5 Tg mice or wild-type (WT) mice were sensitized and repeatedly challenged with ovalbumin (OVA). We examined bronchoalveolar lavage fluid (BALF), lung specimens, and airway hyperresponsiveness (AHR) to methacholine. RESULTS: The production of IFN-gamma by CD4(+) T cells from unprimed SOCS-5 Tg mice was significantly increased in comparison with unprimed wild-type mice, indicating that SOCS-5 Tg mice have a Th1-polarizing condition under natural conditions. However, in an asthma model, significantly more eosinophils in the airways and higher levels of IL-5 and IL-13 in BALF were observed in the SOCS-5 Tg than the wild-type mice. AHR in the asthma model of SOCS-5 Tg was also more enhanced than that of wild-type mice. OVA-stimulated CD4(+) T cells from the primed SOCS-5 Tg mice produced significantly more IL-5 and IL-13 than CD4(+) T cells from wild-type mice. CONCLUSION: Our results demonstrate that the overexpression of SOCS-5 does not inhibit Th2 response, but rather augments the phenotype of the asthma model in vivo. This finding throws into question the therapeutic utility of using enhancement of SOCS-5 expression for Th2-dominant disease. 相似文献
9.
Two-level posterior lumbar interbody fusion for degenerative disc disease: improved clinical outcome with restoration of lumbar lordosis 总被引:2,自引:0,他引:2
Akira Hioki MD Kei Miyamoto MD PhD Hirotaka Kodama MD PhD Hideo Hosoe MD PhD Hirofumi Nishimoto MD Hirofumi Sakaeda MD PhD Katsuji Shimizu MD DMSc 《The spine journal》2005,5(6):600-607
BACKGROUND CONTEXT: Although posterior lumbar interbody fusion (PLIF) for degenerative lumbar diseases is routine, there are few reports on double-level PLIF. PURPOSE: To evaluate the clinical outcomes of double-level PLIF. STUDY DESIGN/SETTING: A retrospective study of operated cases in Gifu, Japan. PATIENT SAMPLE: Nineteen patients (8 men and 11 women, 59.5+/-10.2 years) who underwent double-level PLIF between 1996 and 2001. OUTCOME MEASURES: Operation time, blood loss, complications, the Japanese Orthopaedic Association (JOA) score for back pain and lumbar sagittal alignment were evaluated. METHODS: Patients were examined retrospectively at follow-ups of 3.6+/-1.7 years. Primary diseases were spondylolisthesis, spinal canal stenosis, degenerative scoliosis and herniated intervertebral disc. Fusion areas were L3 to L5 in 15 cases and L4 to S1 in 4 cases. RESULTS: The mean JOA score increased from an initial score of 12.9+/-3.5 to 21.3+/-4.9 at the final follow-up. There was a positive correlation (R=0.718, p<.001) between the increase in lordotic angle and the increase in the JOA score. Several parameters suggested that the surgical invasiveness was not minimal. CONCLUSION: Double-level PLIF provided satisfactory results and preserved lumbar spine lordosis. 相似文献
10.
J T Chen Y Kurokawa K Nakayama K Saito K Sakamoto K Fukuda Y Hirai T Hamada I Fujimoto K Yamauchi 《Nippon Sanka Fujinka Gakkai zasshi》1987,39(5):815-822
Bismuth subnitrate (BSN), a bismuth compound medically used for antidiarrheics, was orally administered to see whether it can reduce CDDP nephrotoxicity or not. Thirteen patients aged 19 approximately 60 with ovarian cancer entered this BSN-CDDP trial. A total of thirty three courses of BSN-CDDP treatment was undergone. BSN was administered orally at a dose of 50 mg/kg for five days before CDDP therapy. CDDP was infused for two hours. No vigorous hydration or diuresis was performed. Only 2,000 ml of saline with 20 mEq per liter of KCl was given for post-hydration. The median dose of CDDP was 100 mg/m2. The renal toxicity of BSN-CDDP treatment was minimum. 82% of the courses at the sixth day after the treatment had creatinine clearance levels which were more than 80% of those before the treatment. But twenty-four hour NAG and beta 2-microglobulin excretion were significantly increased. Bone marrow suppression and gastrointestinal disturbance were commonly observed. The results of our study indicate that BSN pretreatment reduces the renal toxicity of CDDP to some extent. 相似文献